JohnKCamorianoDO

PubMed

• 2 citations
  Pregnancy in patients with myelofibrosis: Mayo–Florence series of 24 pregnancies in 16 women
  Naseema Gangat, Paola Guglielmelli, Aref Al-Kali, Alexandra P. Wolanskyj-Spinner, John K. Camoriano, Mrinal M. Patnaik, Animesh Pardanani, Curtis A. Hanson, Alessandro...> ;British Journal of Haematology. 2021 Jun 14
• 31 citations
  Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers
  Gerardo Colon-Otero, Valentina Zanfagnin, Xiaonan Hou, Nathan R. Foster, Erik Asmus, Andrea E. Wahner Hendrickson, Aminah Jatoi, Matthew S. Block, Carrie L. Langstraat...> ;ESMO Open. 2020 Oct 1
• 15 citations
  Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis
  Rachel J Bubik, Dylan Barth, C. Christopher Hook, Robert C. Wolf, Jessica M. Muth, Kristin C. Mara, Mrinal S. Patnaik, Rajiv K. Pruthi, Ariela L. Marshall, Mark R. Lit...> ;Leukemia & Lymphoma. 2020 Mar 11
• 33 citations
  Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis.
  Krisstina L. Gowin, Heidi E. Kosiorek, Amylou C. Dueck, John Mascarenhas, Ronald Hoffman, Craig B. Reeder, John K. Camoriano, Raoul Tibes, Katherine Gano, Jeanne Palme...> ;Leukemia Research. 2017 Sep 1
• 11 citations
  A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy
  Allison C. Rosenthal, Amylou C. Dueck, Stephen M. Ansell, Katherine Gano, Christopher R. Conley, Grzegorz S. Nowakowski, John K. Camoriano, Jose F. Leis, Joseph R. Mik...> ;American Journal of Hematology. 2017 May 1
• 24 citations
  Pegylated interferon alpha – 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial
  Krisstina L. Gowin, Tania Jain, Heidi E. Kosiorek, Raoul Tibes, John K. Camoriano, Jeanne Palmer, Ruben A. Mesa> ;Leukemia Research. 2017 Mar 1
• Interferon-α and pericardial injury: a case report and literature review
  Fayaz A. Hakim, Sujata Singh, Anil Pandit, Jorge R. Alegria, John K Camoriano, Melissa L. Stanton, Farouk Mookadam> ;Heart Asia. 2014 Apr 1
• 53 citations
  Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia
  Irene M. Ghobrial, Thomas E. Witzig, Morie A. Gertz, Betsy LaPlant, Suzanne R. Hayman, John K. Camoriano, Martha Q. Lacy, P. Leif Bergsagel, Stacey Chuma, Daniel J. De...> ;American Journal of Hematology. 2014 Mar 1
• 153 citations
  BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies
  , , , , , , , , , , , , , , , , , , , , , > ;Leukemia. 2014 Jan 23
• 14 citations
  Ruxolitinib in clinical practice for therapy of myelofibrosis: single USA center experience following Food and Drug Administration approval.
  Holly L. Geyer, Keith Cannon, Emily J. Knight, John K. Camoriano, Robyn M. Emanuel, Raoul Tibes, Ruben A. Mesa> ;Leukemia & Lymphoma. 2014 Jan 1
• 153 citations
  The clinical spectrum of Castleman's disease.
  Angela Dispenzieri, James O. Armitage, Matt J. Loe, Susan Geyer, Jake Allred, John K. Camoriano, David M. Menke, Dennis D. Weisenburger, Kay M. Ristow, Ahmet Dogan, Th...> ;American Journal of Hematology. 2012 Nov 1
• 14 citations
  Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial.
  Steven R. Alberts, Joel M. Reid, Bruce W. Morlan, Gist H. Farr, John K. Camoriano, David B. Johnson, James R. Enger, Thomas E. Seay, George P. Kim> ;American Journal of Clinical Oncology. 2012 Oct 1
• 65 citations
  Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients
  Krisstina Gowin, Prakash Thapaliya, Jan Samuelson, Claire N. Harrison, Deepti Radia, Bjorn Andreasson, John Mascarenhas, Alessandro Rambaldi, Tiziano Barbui, Catherine...> ;Haematologica. 2012 Oct 1
• 38 citations
  Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase.
  , , , , , , , , , , , , , , , > ;Leukemia Research. 2012 Sep 1
• 18 citations
  A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma
  Andrea E. Wahner Hendrickson, Ann L. Oberg, Gretchen E. Glaser, John K. Camoriano, Prema P. Peethambaram, Gerardo Colon-Otero, Charles Erlichman, S. Percy Ivy, Scott H...> ;Gynecologic Oncology. 2012 Feb 1
• 39 citations
  International working group for myelofibrosis research and treatment response assessment and long-term follow-up of 50 myelofibrosis patients treated with thalidomide-...
  Prakash Thapaliya, Ayalew Tefferi, Animesh Pardanani, David P. Steensma, John K. Camoriano, Wenting Wu, Susan Geyer, Ruben A. Mesa> ;American Journal of Hematology. 2011 Jan 1
• 108 citations
  Phase II Trial of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Relapsed or Refractory Waldenström Macroglobulinemia
  Irene M. Ghobrial, Morie A. Gertz, Betsy LaPlant, John K. Camoriano, Suzanne R. Hayman, Martha Q. Lacy, Stacey Chuma, Brianna Harris, Renee Leduc, Meghan Rourke, Steph...> ;Journal of Clinical Oncology. 2010 Mar 10
• 167 citations
  The Myelofibrosis Symptom Assessment Form (MFSAF): An evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis
  Ruben A. Mesa, Susan M. Schwager, Deepti Radia, Andrea L. Cheville, Kebede Hussein, Joyce Niblack, Animesh Pardanani, David P. Steensma, Mark R. Litzow, Candido E. Riv...> ;Leukemia Research. 2009 Sep 1
• Use of KW-2189, a DNA Minor Groove-Binding Agent, in Patients with Hepatocellular Carcinoma: A North Central Cancer Treatment Group (NCCTG) Phase II Clinical Trial.
  Alberts, S.R., Suman, V.J., Pitot, H.C., Camoriano, J.K., Rubin, J.> ;Int J Gastrointest Cancer. 2008-01-03
• 79 citations
  Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey.
  David P. Steensma, Kathleen V. Heptinstall, Victor M. Johnson, Paul J. Novotny, Jeff A. Sloan, John K. Camoriano, Joyce Niblack, John M. Bennett, Ruben A. Mesa> ;Leukemia Research. 2008 May 1
• 26 citations
  A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia
  Ruben A. Mesa, John K. Camoriano, Susan Geyer, Wenting Wu, Scott H. Kaufmann, Candido E. Rivera, Charles Erlichman, John J. Wright, A. Pardanani, Terra L. Lasho, Chris...> ;Leukemia. 2007 Sep 1
• 57 citations
  Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Stu...
  Michael G. Haddock, Revathi Swaminathan, Nathan R. Foster, Mark D. Hauge, James A. Martenson, John K. Camoriano, Philip J. Stella, Richard Charles Tenglin, Paul L. Sch...> ;Journal of Clinical Oncology. 2007 Jun 20
• 8 citations
  Clearance of the Janus kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia.
  Guillermo J. Ruiz-Argüelles, Javier Garcés-Eisele, Virginia Reyes-Núñez, Guillermo J. Ruiz-Delgado, Carlos Rosillo, John K. Camoriano> ;American Journal of Hematology. 2007 May 1
• 8 citations
  Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial.
  Steven R. Alberts, Vera J. Suman, Henry C. Pitot, John K. Camoriano, Joseph Rubin> ;Journal of Gastrointestinal Cancer. 2007 Jan 1
• 286 citations
  The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.
  Ruben A. Mesa, Joyce Niblack, Martha Wadleigh, Srdan Verstovsek, John K. Camoriano, Sunni A. Barnes, Angelina D. Tan, Pamela J. Atherton, Jeff A. Sloan, Ayalew Tefferi> ;Cancer. 2007 Jan 1
• Join now to see all